Dr. Buadi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
200 1st Street SW
Rochester, MN 55905- Is this information wrong?
Education & Training
- Mayo Clinic College of Medicine and ScienceFellowship, Blood & Bone Marrow Transplant, 2002 - 2003
- University of MarylandFellowship, Hematology and Medical Oncology, 1999 - 2002
- St Agnes HealthCareResidency, Internal Medicine, 1996 - 1999
- University of Science and Technology SOMClass of 1991
- School of Medical Sciences, University of Science and TechnologyB.S., 1984 - 1987
Certifications & Licensure
- MN State Medical License 2002 - 2025
- MD State Medical License 1999 - 2008
- TN State Medical License 2004 - 2008
- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- Fellows Program AVENTIS - American Society of Hematology, 2001
- Fellows/Mentors Program AMGEN, American Society of Hematology, 2000
- Honors in Physiology/Biochemistry School of Medical Sciences, University of Science and Technology, 1986
- Join now to see all
Publications & Presentations
PubMed
- Treatment patterns for AL amyloidosis after frontline daratumumab, bortezomib, cyclophosphamide, and dexamethasone treatment failures.Saurabh Zanwar, Morie A Gertz, Eli Muchtar, Francis K Buadi, Taxiarchis Kourelis, Wilson Gonsalves, Ronald S Go, Suzanne Hayman, Prashant Kapoor, Moritz Binder, Josell...> ;Leukemia. 2024 Apr 9
- Outcomes of patients with multiple myeloma refractory to standard dose vs low dose lenalidomide.Utkarsh Goel, Charalampos Charalampous, Prashant Kapoor, Moritz Binder, Francis K Buadi, David Dingli, Angela Dispenzieri, Amie Fonder, Morie A Gertz, Wilson I Gonsalv...> ;Blood Cancer Journal. 2024 Mar 26
- Mode of progression in smoldering multiple myeloma: a study of 406 patients.Abdallah, N., Lakshman, A., Kumar, S., Cook, J., Binder, M., Kapoor, P., Dispenzieri, A., Gertz, M., Lacy, M., Hayman, S., Buadi, F., Dingli, D., Lin, Y., Kourelis, T....> ;Blood Cancer Journal. 2024 Jan 17
- Join now to see all
Journal Articles
- Impact of Prior Diagnosis of Monoclonal Gammopathy on Outcomes in Newly Diagnosed Multiple MyelomaS Vincent Rajkumar, Yi L Hwa, Wilson I Gonsalves, Francis K Buadi, Angela Dispenzieri, Prashant Kapoor, Miriam A Hobbs, Martha Q Lacy, John A Lust, Robert A Kyle, Mori..., Nature
- Safety and Efficacy of Propylene Glycol-Free Melphalan as Conditioning in Patients with AL Amyloidosis Undergoing Stem Cell TransplantationNelson Leung, Prashant Kapoor, Taxiarchis V Kourelis, Eli Muchtar, Angela Dispenzieri, M Hasib Sidiqi, Martha Q Lacy, Wilson I Gonsalves, Shaji K Kumar, Mohammed A Alj..., Nature
- Relapse After Complete Response in Newly Diagnosed Multiple Myeloma: Implications of Duration of Response and Patterns of RelapseAngela Dispenzieri, Francis K Buadi, Morie A Gertz, Martha Q Lacy, Nelson Leung, Amie L Fonder, Wilson I Gonsalves, Yi Lisa Hwa, Taxiarchis Kourelis, Surbhi Sidana, Ro..., Nature
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- A phase ll study (px-171-003-a1) of single-agent carfilzomib in patients with advanced relapsed and refractory multiple myelomaSiegel D, Martin T, Wang M, Vij R, Jakubowiak A, Lonial S, Trudel S, Kukreti V, Bahlis N, Alsina M, Chanan-Khan A, Buadi FK, Reu F, Somlo G, Zonder J, Stewart AK, Stad..., Onkologie, 10/1/2013
- Prediction of poor mobilization of autologous cd34+cells in multiple myeloma (mm): implications for risk-stratificationCosta LJ, Nista EJ, Buadi FK, Lacy MQ, Dispenzieri A, Kramer CP, Kang Y, Gertz MA, Stuart RK, Kumar SK, Transfusion, 9/1/2013
- A phase II study (PX-171-003-A1) of single-agent carfilzomib in patients with advanced relapsed and refractory multiple myeloma (rrmm)Siegel DS, Martin T, Wang M, Vij R, Jakubowiak AJ, Lonial S, Trudel S, Kukreti V, Bahlis N, Alsina M, Chanan-Khan A, Buadi FK, Reu FJ, Somlo G, Zonder J, Song K, Stewa..., Br J Haematol, 4/1/2013
- Join now to see all
Lectures
- Hematologic Malignancies: New Therapies and the Evolving Role of TransplantMayo School of Continuous Professional Development, Chicago, Illinois - 10/11/2013
- Hematologic Malignancies: New Therapies and the Evolving Role of TransplantMayo School of Continuous Professional Development, Chicago, Illinois - 10/11/2013
Other
- Vital statistics, maternal mortality and causes of childhood mortality in the Tanoso district, Brong Ahafo region, Ghana (Thesis)Buadi FK, School of Medical Sciences, University of Science and Technology
Kumasi, Ghana - 8/1/1990 - Polyclonal HypergammaglobulinemiaBuadi FK, Ask Mayo Expert
http://javaprod.mayo.edu/ame/openTopic?collection=1&topicID=4592
Press Mentions
- Comprehensive Care for a Complex Diagnosis Offers New HopeApril 22nd, 2019
- Mayo Clinic Researchers Identify TherapyMarch 9th, 2017
Professional Memberships
- Member
- Member
- Member
Hospital Affiliations
- Mayo Clinic Hospital - RochesterRochester, Minnesota
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: